| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 39, 1390-1397, Copyright © 1993 by American Association for Clinical Chemistry
AB Guttormsen, AM Mansoor, T Fiskerstrand, PM Ueland and H Refsum
Department of Pharmacology and Toxicology, Armauer Hansens Hus, University of Bergen, Norway.
The kinetics of plasma homocysteine were determined in 13 healthy subjects after peroral administration and in one person after intravenous injection. Various forms of homocysteine completely dissolved in an aqueous solution were rapidly absorbed after peroral administration, and the bioavailability was estimated to be 0.53. The volume of distribution was 0.66 L/kg. The area under the plasma concentration curve (AUC0-48 h) was proportional to the administered dose (33.5-134 mumol/kg body wt), and showed small interindividual variations. Plasma homocysteine showed first-order elimination kinetics for at least 6 h. The half-life (t1/2) was 223 +/- 45 min, and there was a significant correlation between t1/2 values determined on two different occasions in the same individual. The transient hyperhomocysteinemia was associated with an increase in plasma methionine, which probably reflects intracellular remethylation of homocysteine. Less than 2% of the administered homocysteine dose was recovered in the urine. These findings may form the basis for future studies on the regulation of plasma homocysteine in health and disease, and should motivate the evaluation of a homocysteine loading test as a diagnostic tool.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  B. L. Urquhart, D. J. Freeman, J. D. Spence, and A. A. House Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis J. Clin. Pharmacol., August 1, 2007; 47(8): 991 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jakubowski Pathophysiological Consequences of Homocysteine Excess J. Nutr., June 1, 2006; 136(6): 1741S - 1749S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Fux, D. Kloor, M. Hermes, T. Rock, B. Proksch, A. Grenz, U. Delabar, R. Bucheler, S. Igel, K. Morike, et al. Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers Am J Physiol Renal Physiol, October 1, 2005; 289(4): F786 - F792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Renwick Establishing the Upper End of the Range of Adequate and Safe Intakes for Amino Acids: A Toxicologist's Viewpoint J. Nutr., June 1, 2004; 134(6): 1617S - 1624S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Powers, A. K. Majors, L. J. Kerchner, and K. P. Conrad Renal Handling of Homocysteine During Normal Pregnancy and Preeclampsia Reproductive Sciences, January 1, 2004; 11(1): 45 - 50. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 R. RAGONE Homocystine solubility and vascular disease FASEB J, March 1, 2002; 16(3): 401 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. FRIEDMAN, A. G. BOSTOM, J. SELHUB, A. S. LEVEY, and I. H. ROSENBERG The Kidney and Homocysteine Metabolism J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2181 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R Olthof, P. C Hollman, P. L Zock, and M. B Katan Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans Am. J. Clinical Nutrition, March 1, 2001; 73(3): 532 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. P. Liu, S. de Keczer, S. Alexander, M. Pirio, D. Davalian, N. Kurn, and E. F. Ullman Homogeneous, Rapid Luminescent Oxygen Channeling Immunoassay (LOCITM) for Homocysteine Clin. Chem., September 1, 2000; 46(9): 1506 - 1507. [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Lentz, R. A. Erger, S. Dayal, N. Maeda, M. R. Malinow, D. D. Heistad, and F. M. Faraci Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta -synthase-deficient mice Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H970 - H975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. LAIVUORI, R. KAAJA, U. TURPEINEN, L. VIINIKKA, and O. YLIKORKALA Plasma Homocysteine Levels Elevated and Inversely Related to Insulin Sensitivity in Preeclampsia Obstet. Gynecol., April 1, 1999; 93(4): 489 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Guttormsen, P. M. Ueland, P. E. Lonning, O. Mella, and H. Refsum Kinetics of Plasma Total Homocysteine in Patients Receiving High-Dose Methotrexate Therapy Clin. Chem., September 1, 1998; 44(9): 1987 - 1989. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
